Oxeia Biopharmaceuticals
Phase 2Join the mission to bring the first FDA-approved treatment for persistent concussion symptoms to market. Visit our campaign page on StartEngine.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $12.5M
About
Join the mission to bring the first FDA-approved treatment for persistent concussion symptoms to market. Visit our campaign page on StartEngine.
Small Molecules
Funding History
2Total raised:$12.5M
Series A$10MMar 15, 2022
Seed$2.5MJun 15, 2021